Early Prediction of Treatment Response of Neuroendocrine Hepatic Metastases after Peptide Receptor Radionuclide Therapy with 90Y-DOTATOC Using Diffusion Weighted and Dynamic Contrast-Enhanced MRI

Early Prediction of Treatment Response of Neuroendocrine Hepatic Metastases after Peptide Receptor Radionuclide Therapy with 90Y-DOTATOC Using Diffusion Weighted and Dynamic Contrast-Enhanced MRI

The purpose of this study was to determine if parameters derived from diffusion-weighted (DW-) and dynamic contrast-enhanced (DCE-) magnetic resonance imaging (MRI) can help to assess early response to peptide receptor radionuclide therapy (PRRT) with 90Y-DOTATOC in neuroendocrine hepatic metastases...

Full description

Bibliographic Details
Main Authors: Thomas Weikert, Ole Christopher Maas, Tanja Haas, Markus Klarhöfer, Jens Bremerich, Flavio Forrer, Alexander Walter Sauter, Gregor Sommer
Format: Article
Language:English
Published: Hindawi-Wiley 2019-01-01
Series:Contrast Media & Molecular Imaging
Online Access:http://dx.doi.org/10.1155/2019/1517208

Internet

http://dx.doi.org/10.1155/2019/1517208

Similar Items